ISSUE: 2002/07/a To view an abstract click on the title of the desired article. This will request Medline details from PubMed which is provided by the National Library of Medicine. After viewing the abstract use your browser's [Back] button to return to this page.

Contents

References: Clinical / Prognostic Markers

References: Basic Science / Neuroblastoma Research

References: Neurobiology / Cell Physiology Research   (neuroblastoma cell lines)

Previous Issue of Recent Publications (2002/06/a)

Back to NBL-PROF Home Page

Clinical / Prognostic Markers

Anderson J, et al. Neuroblastoma in monozygotic twins - a case of probable twin to twin metastasis. Br J Cancer 2002 May 20;86(10):1666    [Related articles]

Garaventa A, et al. Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors. Ann Oncol 2002 Jun;13(6):956-64    [Related articles]

Haberle B, et al. Characteristics and outcome of thoracic neuroblastoma. Eur J Pediatr Surg 2002 Jun;12(3):145-50    [Related articles]

Holzer R, et al. Congenital heart disease and neuroblastoma: just coincidence? Arch Dis Child 2002 Jul;87(1):61-4    [Related articles]

Lonergan GJ, et al. From the Archives of the AFIP : Neuroblastoma, Ganglioneuroblastoma, and Ganglioneuroma: Radiologic-Pathologic Correlation. Radiographics 2002 Jul;22(4):911-934    [Related articles]

Martin PJ, et al. Reporting of adverse event data in hematopoietic stem cell transplantation clinical trials involving investigational new drugs or devices: a report from the William Guy Forbeck Foundation 2001 focus meeting Biol Blood Marrow Transplant 2002;8(6):295-302    [Related articles]

Massimo L. Neuroblastoma: a challenge for pediatric oncology of the third millennium. Ann N Y Acad Sci 2002 Jun;963:59-62    [Related articles]

Morris JK. Screening for neuroblastoma in children. J Med Screen 2002;9(2):56    [Related articles]     Screening

Nishi M, et al. Contribution of HPLC mass screening for neuroblastoma to a decrease in mortality. J Exp Clin Cancer Res 2002 Mar;21(1):73-8    [Related articles]     Screening

Okuyama C, et al. Utility of follow-up studies using meta-[123 I]iodobenzylguanidine scintigraphy for detecting recurrent neuroblastoma. Nucl Med Commun 2002 Jul;23(7):663-72    [Related articles]

Schwab M. Amplified MYCN in human neuroblastoma: paradigm for the translation of molecular genetics to clinical oncology. Ann N Y Acad Sci 2002 Jun;963:63-73    [Related articles]     MYCN Amplification

Stanford A, et al. Surgical management of open versus laparoscopic adrenalectomy: Outcome analysis. J Pediatr Surg 2002 Jul;37(7):1027-9    [Related articles]

Sterba J. Contemporary therapeutic options for children with high risk neuroblastoma. Neoplasma 2002;49(3):133-40    [Related articles]

Suita S. Mass screening for neuroblastoma in Japan: Lessons learned and future directions. J Pediatr Surg 2002 Jul;37(7):949-54    [Related articles]     Screening

Basic Science / Neuroblastoma Research

Auf G, et al. CpG-oligodeoxynucleotide rejection of a neuroblastoma in A/J mice does not induce a paraneoplastic disease. Neurosci Lett 2002 Jul 26;327(3):189-92    [Related articles]

Beniashvili DSh, et al. [Induction of tumors of the sympathetic nervous system in rats] Vopr Onkol 2002;48(1):52-6    [Related articles]

Bernardini S, et al. Role of GST P1-1 in mediating the effect of etoposide on human neuroblastoma cell line Sh-Sy5y. J Cell Biochem 2002;86(2):340-7    [Related articles]

Bryson GJ, et al. Detection of the CD56+/CD45- immunophenotype by flow cytometry in neuroendocrine malignancies. J Clin Pathol 2002 Jul;55(7):535-537    [Related articles]

Cheung IY, et al. Quantitation of GD2 synthase mRNA by real-time reverse transcription-polymerase chain reaction. Cancer 2002 Jun 1;94(11):3042-8    [Related articles]

Combaret V, et al. Circulating MYCN DNA as a Tumor-specific Marker in Neuroblastoma Patients. Cancer Res 2002 Jul 1;62(13):3646-8    [Related articles]     MYCN Amplification

Dirks WG, et al. Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines. Int J Cancer 2002 Jul 1;100(1):49-56    [Related articles]

Fulda S, et al. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 2002 Jul 15; [epub ahead of print]    [Related articles]

Giordani L, et al. Two regions of deletion in 9p22 approximately p24 in neuroblastoma are frequently observed in favorable tumors. Cancer Genet Cytogenet 2002 May;135(1):42-7    [Related articles]

Grant MK, et al. Endogenous expression of nNOS protein in several neuronal cell lines. Life Sci 2002 Jul 5;71(7):813-7    [Related articles]

Harada K, et al. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene 2002 Jun 20;21(27):4345-9    [Related articles]

Hatori K, et al. Fractalkine and fractalkine receptors in human neurons and glial cells. J Neurosci Res 2002 Aug 1;69(3):418-26    [Related articles]

Iwasaki I, et al. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles. Cancer Chemother Pharmacol 2002 Jun;49(6):438-44    [Related articles]

Khanna C, et al. Biologically relevant orthotopic neuroblastoma xenograft models: primary adrenal tumor growth and spontaneous distant metastasis. In Vivo 2002 Mar-Apr;16(2):77-85    [Related articles]

Kutlik MT, et al. Glutathione S-transferase and P-glycoprotein expressions in neuroblastoma. Pediatr Hematol Oncol 2002 Jul-Aug;19(5):337-45    [Related articles]

Lastowska M, et al. Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors. Genes Chromosomes Cancer 2002 Aug;34(4):428-36    [Related articles]     Chromosome 17q

Lee YS, et al. Redox status-dependent regulation of cyclooxygenases mediates the capsaicin-induced apoptosis in human neuroblastoma cells. J Environ Pathol Toxicol Oncol 2002;21(2):113-20    [Related articles]

Noujaim D, et al. N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells. Oncogene 2002 Jul 4;21(29):4549-57    [Related articles]     MYCN Amplification

Rana B, et al. Retinoid X receptors and retinoid response in neuroblastoma cells. J Cell Biochem 2002;86(1):67-78    [Related articles]

Rapella A, et al. Flavopiridol inhibits vascular endothelial growth factor production induced by hypoxia or picolinic acid in human neuroblastoma. Int J Cancer 2002 Jun 10;99(5):658-64    [Related articles]

Sekhon J, et al. Antisense inhibition of methylenetetrahydrofolate reductase reduces survival of methionine-dependent tumour lines. Br J Cancer 2002 Jul 15;87(2):225-230    [Related articles]

Sepe PS, et al. Role of the Aspartyl-Asparaginyl-beta-Hydroxylase Gene in Neuroblastoma Cell Motility. Lab Invest 2002 Jul;82(7):881-91    [Related articles]

Takahashi K, et al. Expression of prolactin-releasing peptide and its receptor in the human adrenal glands and tumor tissues of adrenocortical tumors, pheochromocytomas and neuroblastomas. Peptides 2002 Jun;23(6):1135-40    [Related articles]

Tytgat GA, et al. Human megakaryocytes cultured in vitro accumulate serotonin but not meta-iodobenzylguanidine whereas platelets concentrate both. Exp Hematol 2002 Jun;30(6):555-63    [Related articles]

Vandesompele J, et al. A brief commentary on "Chromosomal aberrations in neuroblastoma cell lines identified by cross species color banding and chromosome painting". Cancer Genet Cytogenet 2002 Jun;135(2):196    [Related articles]

Westermann F, et al. Genetic parameters of neuroblastomas. Cancer Lett 2002 Oct 28;184(2):127-47    [Related articles]

Yazawa T, et al. Complicated Mechanisms of Class II Transactivator Transcription Deficiency in Small Cell Lung Cancer and Neuroblastoma. Am J Pathol 2002 Jul;161(1):291-300    [Related articles]

Neurobiology / Cell Physiology Research   (neuroblastoma cell lines)

Andoh T, et al. Preconditioning-mediated neuroprotection: role of nitric oxide, cGMP, and new protein expression. Ann N Y Acad Sci 2002 May;962:1-7    [Related articles]

Bettendorff L, et al. ATP-driven, Na(+) -independent inward Cl(-) pumping in neuroblastoma cells. J Neurochem 2002 May;81(4):792-801    [Related articles]

Bonetto V, et al. Synthetic miniprion PrP106. J Biol Chem 2002 Jun 10; [epub ahead of print]    [Related articles]

Bronisz A, et al. PKC and Raf-1 inhibition-related apoptotic signalling in N2a cells. J Neurochem 2002 Jun;81(6):1176-84    [Related articles]

Conn KJ, et al. Specific up-regulation of GADD153/CHOP in 1-methyl-4-phenyl-pyridinium-treated SH-SY5Y cells. J Neurosci Res 2002 Jun 15;68(6):755-60    [Related articles]

D'Orlando C, et al. Calretinin and calbindin D-28k, but not parvalbumin protect against glutamate-induced delayed excitotoxicity in transfected N18-RE 105 neuroblastoma-retina hybrid cells. Brain Res 2002 Aug 2;945(2):181-90    [Related articles]

De Jaco A, et al. Muscarinic acetylcholine receptors induce neurite outgrowth and activate the synapsin I gene promoter in neuroblastoma clones. Neuroscience 2002;113(2):331-8    [Related articles]

Feng Z, et al. Neuronal Differentiation and Protection from Nitric Oxide-Induced Apoptosis Require c-Jun-Dependent Expression of NCAM140. Mol Cell Biol 2002 Aug;22(15):5357-66    [Related articles]

Fukushima N, et al. Lysophosphatidic Acid influences the morphology and motility of young, postmitotic cortical neurons. Mol Cell Neurosci 2002 Jun;20(2):271-82    [Related articles]

Gomez-Santos C, et al. MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res 2002 May 10;935(1-2):32-9    [Related articles]

Greenwood JM, et al. Muscarinic receptor-mediated phosphorylation of cyclic AMP response element binding protein in human neuroblastoma cells. J Neurochem 2002 Jul;82(2):389-97    [Related articles]

Kelicen P, et al. The spin trapping agent PBN stimulates H2 O2 -induced Erk and Src kinase activity in human neuroblastoma cells. Neuroreport 2002 Jun 12;13(8):1057-61    [Related articles]

Kumar B, et al. Mevastatin induces degeneration and decreases viability of cAMP-induced differentiated neuroblastoma cells in culture by inhibiting proteasome activity, and mevalonic acid lactone prevents these effects. J Neurosci Res 2002 Jun 1;68(5):627-35    [Related articles]

Levites Y, et al. Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol, (-)-epigallocatechin-3-gallate neuroprotective action. J Biol Chem 2002 Jun 10;    [Related articles]

Li PC, et al. Enhanced activity of Ca2+-activated K+ channels by 1-[2-hydroxy-3-propyl-4-[(1H-tetrazol-5-yl)butoxyl]phenyl] ethanone (LY-171883) in neuroendocrine and neuroblastoma cell lines. J Cell Physiol 2002 Aug;192(2):188-99    [Related articles]

O'Reilly N, et al. Disparity between ionic mediators of volume regulation and apoptosis in N1E 115 mouse neuroblastoma cells. Brain Res 2002 Jul 12;943(2):245-56    [Related articles]

Thelen K, et al. The neural cell adhesion molecule L1 potentiates integrin-dependent cell migration to extracellular matrix proteins. J Neurosci 2002 Jun 15;22(12):4918-31    [Related articles]

Wallington CL, et al. Orphanin FQ/nociceptin and &mgr;-opioid receptor mRNA levels in human SH-SY5Y neuroblastoma cells: effects of activating the cAMP-PKA signal transduction pathway. Brain Res 2002 Jul 19;944(1-2):73-81    [Related articles]

Zhang J, et al. Cdk5 phosphorylates p53 and regulates its activity. J Neurochem 2002 Apr;81(2):307-13    [Related articles]

Zhen XG, et al. AVP(4-8) Enhances PKC and MAPK Activities in SK-N-SH Cells. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2000;32(2):105-108    [Related articles]

Zuddas A, et al. 6R-Tetrahydrobiopterin induces dopamine synthesis in a human neuroblastoma cell line, LA-N-1. A cellular model of Dopa-responsive dystonia. Brain Res 2002 Jul 12;943(2):257-62    [Related articles]

Previous Issue of Recent Publications (2002/06/a)
Back to NBL-PROF Home Page